Augmentation strategy with olanzapine in resistant obsessive compulsive disorder: an Italian long-term open-label study.

@article{Marazziti2005AugmentationSW,
  title={Augmentation strategy with olanzapine in resistant obsessive compulsive disorder: an Italian long-term open-label study.},
  author={Donatella Marazziti and Chiara Pfanner and Bernardo Dell'osso and Antonio Ciapparelli and Silvio Presta and Giorgio Corretti and Elena Di Nasso and Francesco Mungai and Liliana Dell'osso},
  journal={Journal of psychopharmacology},
  year={2005},
  volume={19 4},
  pages={392-4}
}
The present study reports the results of an open-label trial on the use of the combination of olanzapine (an atypical antipsychotic) serotonin reuptake inhibitors (SRIs) in 26 resistant outpatients affected by resistant obsessive-compulsive disorder (OCD). All patients had been suffering from OCD, according to DSM IV criteria, for at least 2 years and had different comorbid disorders; they had been treated with an SRI at adequate dosages for at least 6 months, or had tried different… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 16 extracted citations

Efficacy of treatments for patients with obsessive-compulsive disorder: a systematic review.

Journal of the American Academy of Nurse Practitioners • 2009
View 1 Excerpt

Similar Papers

Loading similar papers…